Tilray | TRLY - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
9.23
Cambio Giornaliero
-0.23 -2.43%
Mensile
-3.75%
Annuale
1,237.68%
Q2 Previsione
9.04




Spese Di Vendita E Di Amministrazione Cambiamento Data
Acasti Pharma USD 1.96M 180K 2025-09
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Avita Medical AUD 19.03M 1.95M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Cronos Group USD 19.45M 4.9M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Moderna USD 308M 40M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Organon & Co USD 399M 54M 2025-09
Revvity USD 251.73M 9.82M 2025-12
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12